SAVIENT PHARMACEUTICALS INC: cashflow_financing

Value{"amount": 222845000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2011-01-01 – 2011-03-31
Statussuperseded
EntitySAVIENT PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-11-134352 · Open the official SEC filing →
Retrieved: 2026-08-19T07:42:09.071666+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000722104/cashflow-financing/2011-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/25fc7288-fb79-4c4a-96d8-8db05f9ab3a6

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies